According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster ...
COVID-19 vaccination during pregnancy may lower the risk for preeclampsia and other complications, according to new data.The findings “support the importance of strengthening COVID vaccination ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online Feb. 18 in eClinicalMedicine.
In a recent study published in The Lancet Regional Health Western Pacific, researchers compare the immunogenicity, reactogenicity, and safety of a half-dose Pfizer-BioNTech BNT162b2 coronavirus ...